Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 931

Tokopedia locks up $1bn in SoftBank-led round

SoftBank has reportedly led a round that valued the peer-to-peer e-commerce platform, which also counts Alibaba and CyberAgent as investors, at about $7bn.

Nov 21, 2018

Finleap jumps on $47m

Ping An has led a $47.3m investment in Finleap through its Global Voyager Fund, joining a list of shareholders that already included Hannover Re and Signal Iduna.

Nov 21, 2018

MapAnything drives away with series C funding

The geolocation software provider received $42.5m in a round that included GM Ventures and Salesforce Ventures, taking its total funding to about $83m.

Nov 21, 2018

Inflazome gets series B funding influx

Inflammatory disease drug developer Inflazome, based on research at University of Queensland and Trinity College Dublin, has added $45.6m in series B capital to its coffers.

Nov 21, 2018

BillDesk itemises $300m Visa investment

Visa has provided a reported $200m in equity funding for bill payment platform BillDesk and bought up to $100m worth of shares in a secondary transaction.

Nov 20, 2018

Corporates take Leap in $288m series A

Leap Motor has received $288m in a round co-led by Shanghai Electric and CRRC as it prepares to launch its smart electric sports car early next year.

Nov 20, 2018

Acorns to manage $100m investment

PayPal and Rakuten-backed savings platform Acorns Grow is looking to raise more than $100m in a corporate-led round that will value it at $700m.

Nov 20, 2018

Xiaoqule bands together investors to raise $108m

The community-focused e-commerce platform has raised series A funds from investors including Ping An Ventures and SIG Asia.

Nov 20, 2018

Vascugen generates funding

Vascugen has collected an undisclosed sum from investors including Indiana University Philanthropic Venture Fund to commercialise medicines for vascular-degenerative diseases based on IU technology.

Nov 20, 2018

Novartis and Clal help inject $40m into Cadent

Novartis and Access Industries unit Clal Biotechnology Industries both took part in the neurological disorder drug developer's series B round.

Nov 20, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here